CRWV Insider Notice: 3,512 RSU Shares to Be Sold via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice of proposed sale under Rule 144 for CoreWeave, Inc. (CRWV). The filing shows 3,512 common shares proposed to be sold through Morgan Stanley Smith Barney LLC on 08/26/2025 with an aggregate market value of $324,438.56. The shares were reported as acquired on 08/20/2025 as Restricted Stock Units issued by the issuer, with payment dated 08/20/2025. The filing also discloses a sale within the past three months by the same person, Nitin Agrawal, of 6,010 shares on 08/20/2025 for gross proceeds of $540,858.53. The filing includes the representation that the selling person does not possess undisclosed material adverse information about the issuer.
Positive
- Filing complies with Rule 144 disclosure, providing broker, quantity, value, and planned sale date
- Securities were acquired as Restricted Stock Units, with acquisition and payment dates clearly stated (08/20/2025)
- Prior sale disclosed for transparency: 6,010 shares sold on 08/20/2025 for $540,858.53
Negative
- None.
Insights
TL;DR: Routine insider filing disclosing a small RSU-derived sale; no material impact on cap table evident.
The Form 144 documents a proposed sale of 3,512 common shares acquired as Restricted Stock Units on 08/20/2025, to be executed via Morgan Stanley Smith Barney on 08/26/2025. The aggregate value reported is $324,438.56. Given the reported shares outstanding of 370,470,348, the proposed sale represents an immaterial fraction of total equity. The filing also discloses a prior sale of 6,010 shares on 08/20/2025 for $540,858.53. This notice meets disclosure requirements under Rule 144 and provides transparency on insider-derived share dispositions.
TL;DR: Compliance-focused disclosure; shows insider adherence to Rule 144 notice obligations.
The filer affirms the absence of undisclosed material adverse information and provides details on acquisition type (Restricted Stock Units), acquisition and payment dates, broker, and planned sale date. The filing demonstrates completion of required procedural disclosures for an insider sale under Rule 144. No governance issues or other corporate actions are described in the filing text.